CellaVision AB (publ) (OTCMKTS:CLVSF) Short Interest Update

CellaVision AB (publ) (OTCMKTS:CLVSF) saw a large decline in short interest in January. As of January 15th, there was short interest totaling 5,239 shares, a decline of 54.0% from the December 31st total of 11,378 shares. Based on an average trading volume of 20 shares, the days-to-cover ratio is presently 262.0 days. Based on an average trading volume of 20 shares, the days-to-cover ratio is presently 262.0 days.

CellaVision AB (publ) Price Performance

Shares of OTCMKTS CLVSF opened at $17.30 on Friday. The company’s fifty day simple moving average is $16.94 and its 200 day simple moving average is $18.31. CellaVision AB has a 12-month low of $16.69 and a 12-month high of $17.30.

CellaVision AB (publ) Company Profile

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.